The earnings call for Fortrea's second quarter of 2025 highlighted strong revenue growth and positive cash flow, driven by the clinical pharmacology segment and operational efficiencies. However, these positives were offset by a significant net loss due to goodwill impairment and challenges in securing new business from biotech customers amid a leadership transition.

Company Guidance

During the Fortrea Second Quarter 2025 Earnings Conference Call, the company provided updated guidance and shared various performance metrics. Fortrea reported a second-quarter revenue of $710.3 million and an adjusted EBITDA of $54.9 million. The company's backlog as of June 30, 2025, was $7.5 billion, with a book-to-bill ratio of 0.79x for the quarter and 1.1x for the trailing 12 months. Despite some customer hesitancy, particularly among new biotech clients, Fortrea maintained consistent win rates with existing large pharma and biotech customers. The company also achieved positive cash flow, with a sound liquidity position and a balanced capital structure. Fortrea's revenue guidance for the year was increased, with the EBITDA range reaffirmed. Operational highlights included the successful delivery of a bioequivalence trial ahead of schedule and strong metrics in clinical projects. The company is also investing in innovation, introducing new modules in its Accelerate software platform, including an AI-powered Risk Radar. Fortrea continues to focus on cost optimization, having achieved a third of its $150 million gross savings target in the first half of 2025.

Revenue Growth

Fortrea reported revenue of $710.3 million for the second quarter, indicating a growth of 7.2% compared to the same period last year.

Positive Cash Flow

The company generated positive operating cash flow of $21.8 million and free cash flow of $14.3 million in the second quarter.

Clinical Pharmacology Segment Performance

The clinical pharmacology reporting unit showed strong performance, contributing significantly to the company's revenue growth.

Operational Efficiency

The company improved its days sales outstanding (DSO) by 5 days compared to the first quarter, demonstrating improved operational efficiency.

Introduction of Innovative Technology

Fortrea introduced Risk Radar, an AI-powered tool designed to enhance risk-based quality management in clinical trials.

Fortrea Holdings Inc. (FTRE) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

FTRE Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Nov 17, 2025	2025 (Q3)	0.15 / -	0.23	―	―	―
Aug 06, 2025	2025 (Q2)	0.08 / 0.19	-0.03	733.33% (+0.22)
May 12, 2025	2025 (Q1)	-0.05 / 0.02	-0.04	150.00% (+0.06)
Mar 03, 2025	2024 (Q4)	0.36 / 0.18	0.19	-5.26% (-0.01)
Nov 08, 2024	2024 (Q3)	0.25 / 0.23	0.24	-4.17% (>-0.01)
Aug 12, 2024	2024 (Q2)	0.07 / -0.03	0.52	-105.77% (-0.55)
May 13, 2024	2024 (Q1)	<0.01 / -0.04	0.454	-108.81% (-0.49)
Mar 11, 2024	2023 (Q4)	0.23 / 0.19	―	―
Nov 13, 2023	2023 (Q3)	0.16 / 0.24	0.682	-64.81% (-0.44)	―
Aug 14, 2023	2023 (Q2)	0.39 / 0.52	0.748	-30.48% (-0.23)	―

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

FTRE Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
Aug 06, 2025	$6.56	$6.58	+0.30%
May 12, 2025	$6.15	$5.19	-15.61%
Mar 03, 2025	$13.85	$10.38	-25.05%
Nov 08, 2024	$18.05	$23.50	+30.19%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Fortrea Holdings Inc. (FTRE) report earnings?

Fortrea Holdings Inc. (FTRE) is schdueled to report earning on Nov 17, 2025, Before Open (Confirmed).

What is Fortrea Holdings Inc. (FTRE) earnings time?

Fortrea Holdings Inc. (FTRE) earnings time is at Nov 17, 2025, Before Open (Confirmed).

Where can I see when companies are reporting earnings?

You can see which companies are reporting today on our designated earnings calendar.

What companies are reporting earnings today?

You can see a list of the companies which are reporting today on TipRanks earnings calendar.

What is FTRE EPS forecast?

FTRE EPS forecast for the fiscal quarter 2025 (Q3) is 0.15.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing